Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Flourishing for Peace

15 listopada 2026 zaktualizowane przez: Universidad del Sinú - Elías Bechara Zainúm

Flourishing for Peace Curriculum (Currículo de Florecimiento Para la Paz)

This study is a six-arm individually randomized group-treated (IRGT) trial comparing five16-week standalone flourishing curricula conditions with a control condition consisting of the regular curriculum. Participants will be individually randomized to one of the six conditions. Self-report variables and heart rate variability (HRV) data will be assessed at four time points: T1 (baseline, before the curriculum begins), T2 (8-week midterm), T3 (16-week, at the end of the curriculum), and T4 (beginning of next term), with the main outcome testing changes between T1 and T3. Primary outcomes include the lnRMSSD as a measure of HRV and the overall self-reported flourishing score. Secondary outcomes include 20 domain specific psychological scales and two other HRV measures (SDNN, and mean heart rate). Course-specific knowledge tests will also be administered to gauge participant engagement and course effectiveness. Study results will be reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT) guidelines for non-pharmacological interventions.

Przegląd badań

Typ studiów

Interwencyjne

Zapisy (Szacowany)

1050

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

Lokalizacje studiów

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat i starsze (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Tak

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  • (a) enrollment as a university student at UniSinu; (b) intention to remain in the campus area for at least 12 months and express a commitment to try to remain engaged in the study from beginning to end; and (c) ability to read, speak, and understand Spanish.

Exclusion Criteria:

  • No

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Podstawowa nauka
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Potroić

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Resilience and Self-Control

This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Resilience and Self-Control

Eksperymentalny: Stress, Coping, and Forgiveness

This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Stress, Coping, and Forgiveness

Eksperymentalny: Mindfulness and Meaning and Purpose

This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Mindfulness will be taught in 8 of the 16 weeks and Meaning and Purpose will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Mindfulness and Meaning and Purpose

Eksperymentalny: Quality of Relationships for Peace and Positive Emotions

This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Quality of Relationships for Peace will be taught in 8 of the 16 weeks and Positive Emotions will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Quality of Relationships for Peace and Positive Emotions

Eksperymentalny: Emotional Intelligence, Forgiveness, and Spirituality

This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Emotional Intelligence, Forgiveness, and Spirituality

Aktywny komparator: Regular course

Participants assigned to the control condition will continue with their regular university coursework but complete the same measures as the intervention conditions.

Regular course

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Overall Flourishing: Flourish Measure
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Use the total score across 10 items of the Flourish measure developed by Tyler VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
lnRMSSD
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Heart rate variability (HRV) will be collected using a validated chest-strap sensor ( the Polar H10; Polar Electro, Kempele, Finland) during standardized resting assessments. The natural logarithm of the root mean square of successive differences between normal RR intervals (lnRMSSD), a time-domain measure of short-term heart rate variability and vagal/parasympathetic regulation, will be used as the primary HRV outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Happiness and Life Satisfaction: subscale of Flourish Measure
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Mental and Physical Health: subscale of Flourish Measure
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Meaning and Purpose: subscale of Flourish Measure
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Character and Virtue: subscale of Flourish Measure
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Close Social Relationships: subscale of Flourish Measure
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Depression symptoms: Patient Health Questionnaire-9 (PHQ-9)
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 0 to 3. Higher score indicates more severe depressive symptoms.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Anxiety Symptoms: Generalized Anxiety Disorder-7 (GAD-7)
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 0 to 3. Higher scores more severe anxiety symptoms.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
The Short Stress Overload Scale
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher stress.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Coherence: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 7. Higher score indicates higher meaning.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Purpose: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 7. Higher score indicates higher meaning.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Significance: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 7. Higher score indicates higher meaning.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Trait Forgivingness Scale
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher forgiveness.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Trait Humility: subscale of Relational Humility Scale
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher humility.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 4. Higher score indicates higher mindfulness.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Brief Self-Control Scale
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher self-control

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Brief Resilience Scale
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher resilience.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Loneliness: NIH Toolbox Adult Social Relationship Scales
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher level of loneliness

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Transcendent Spirituality: subscale of Trait Sources of Spirituality Scale
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher level of spirituality

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Persevering Hope Scale
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher level of hope

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Coping Self-Efficacy Scale
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 0 to 10. Higher score indicates higher level of self-efficacy

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
SDNN
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Standard Deviation of Normal-to-Normal intervals, another HRV measure

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Mean Heart Rate
Ramy czasowe: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Mean Heart Rate

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Szacowany)

1 stycznia 2027

Zakończenie podstawowe (Szacowany)

1 sierpnia 2027

Ukończenie studiów (Szacowany)

1 grudnia 2027

Daty rejestracji na studia

Pierwszy przesłany

15 listopada 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

15 listopada 2026

Pierwszy wysłany (Rzeczywisty)

20 listopada 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

20 listopada 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

15 listopada 2026

Ostatnia weryfikacja

1 listopada 2026

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • Acta No. 005 de 2025

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIE

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj